Literature DB >> 20682806

Animal models of orthopoxvirus infection.

J L Chapman1, D K Nichols, M J Martinez, J W Raymond.   

Abstract

Smallpox was one of the most devastating diseases known to humanity. Although smallpox was eradicated through a historically successful vaccination campaign, there is concern in the global community that either Variola virus (VARV), the causative agent of smallpox, or another species of Orthopoxvirus could be used as agents of bioterrorism. Therefore, development of countermeasures to Orthopoxvirus infection is a crucial focus in biodefense research, and these efforts rely on the use of various animal models. Smallpox typically presented as a generalized pustular rash with 30 to 40% mortality, and although smallpox-like syndromes can be induced in cynomolgus macaques with VARV, research with this virus is highly restricted; therefore, animal models with other orthopoxviruses have been investigated. Monkeypox virus causes a generalized vesiculopustular rash in rhesus and cynomolgus macaques and induces fatal systemic disease in several rodent species. Ectromelia virus has been extensively studied in mice as a model of orthopoxviral infection in its natural host. Intranasal inoculation of mice with some strains of vaccinia virus produces fatal bronchopneumonia, as does aerosol or intranasal inoculation of mice with cowpox virus. Rabbitpox virus causes pneumonia and fatal systemic infections in rabbits and can be naturally transmitted between rabbits by an aerosol route similar to that of VARV in humans. No single animal model recapitulates all known aspects of human Orthopoxvirus infections, and each model has its advantages and disadvantages. This article provides a brief review of the Orthopoxvirus diseases of humans and the key pathologic features of animal models of Orthopoxvirus infections.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20682806     DOI: 10.1177/0300985810378649

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  57 in total

Review 1.  The effects of post-exposure smallpox vaccination on clinical disease presentation: addressing the data gaps between historical epidemiology and modern surrogate model data.

Authors:  M Shannon Keckler; Mary G Reynolds; Inger K Damon; Kevin L Karem
Journal:  Vaccine       Date:  2013-08-27       Impact factor: 3.641

2.  Evaluation of monkeypox disease progression by molecular imaging.

Authors:  Julie Dyall; Reed F Johnson; Dar-Yeong Chen; Louis Huzella; Dan R Ragland; Daniel J Mollura; Russell Byrum; Richard C Reba; Gerald Jennings; Peter B Jahrling; Joseph E Blaney; Jason Paragas
Journal:  J Infect Dis       Date:  2011-10-19       Impact factor: 5.226

3.  Assessment of the protective effect of Imvamune and Acam2000 vaccines against aerosolized monkeypox virus in cynomolgus macaques.

Authors:  Graham J Hatch; Victoria A Graham; Kevin R Bewley; Julia A Tree; Mike Dennis; Irene Taylor; Simon G P Funnell; Simon R Bate; Kimberley Steeds; Thomas Tipton; Thomas Bean; Laura Hudson; Deborah J Atkinson; Gemma McLuckie; Melanie Charlwood; Allen D G Roberts; Julia Vipond
Journal:  J Virol       Date:  2013-05-08       Impact factor: 5.103

4.  MyD88-dependent immunity to a natural model of vaccinia virus infection does not involve Toll-like receptor 2.

Authors:  Michael L Davies; Janet J Sei; Nicholas A Siciliano; Ren-Huan Xu; Felicia Roscoe; Luis J Sigal; Laurence C Eisenlohr; Christopher C Norbury
Journal:  J Virol       Date:  2014-01-08       Impact factor: 5.103

5.  Intrabronchial inoculation of cynomolgus macaques with cowpox virus.

Authors:  Alvin L Smith; Marisa St Claire; Srikanth Yellayi; Laura Bollinger; Peter B Jahrling; Jason Paragas; Joseph E Blaney; Reed F Johnson
Journal:  J Gen Virol       Date:  2011-09-21       Impact factor: 3.891

6.  Pathogenesis of fulminant monkeypox with bacterial sepsis after experimental infection with West African monkeypox virus in a cynomolgus monkey.

Authors:  Noriyo Nagata; Masayuki Saijo; Michiyo Kataoka; Yasushi Ami; Yuriko Suzaki; Yuko Sato; Naoko Iwata-Yoshikawa; Momoko Ogata; Ichiro Kurane; Shigeru Morikawa; Tetsutaro Sata; Hideki Hasegawa
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

7.  Natural Killer Cells and Innate Interferon Gamma Participate in the Host Defense against Respiratory Vaccinia Virus Infection.

Authors:  Georges Abboud; Vikas Tahiliani; Pritesh Desai; Kyle Varkoly; John Driver; Tarun E Hutchinson; Shahram Salek-Ardakani
Journal:  J Virol       Date:  2015-10-14       Impact factor: 5.103

8.  Evaluation of monkeypox virus infection of black-tailed prairie dogs (Cynomys ludovicianus) using in vivo bioluminescent imaging.

Authors:  Elizabeth A Falendysz; Angela M Londoño-Navas; Carol U Meteyer; Nicola Pussini; Juan G Lopera; Jorge E Osorio; Tonie E Rocke
Journal:  J Wildl Dis       Date:  2014-04-29       Impact factor: 1.535

9.  The mature virion of ectromelia virus, a pathogenic poxvirus, is capable of intrahepatic spread and can serve as a target for delayed therapy.

Authors:  Xueying Ma; Ren-Huan Xu; Felicia Roscoe; J Charles Whitbeck; Roselyn J Eisenberg; Gary H Cohen; Luis J Sigal
Journal:  J Virol       Date:  2013-04-17       Impact factor: 5.103

10.  CD8 T cells use IFN-γ to protect against the lethal effects of a respiratory poxvirus infection.

Authors:  John Goulding; Georges Abboud; Vikas Tahiliani; Pritesh Desai; Tarun E Hutchinson; Shahram Salek-Ardakani
Journal:  J Immunol       Date:  2014-04-18       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.